DAWN: Day One Biopharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 685.16
Enterprise Value ($M) 560.19
Book Value ($M) 502.75
Book Value / Share 4.96
Price / Book 1.36
NCAV ($M) 482.29
NCAV / Share 4.76
Price / NCAV 1.42

Profitability (mra)
Return on Invested Capital (ROIC) -0.19
Return on Assets (ROA) -0.29
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 7.61
Current Ratio 7.66

Balance Sheet (mrq) ($M)
Current Assets 562.33
Assets 582.79
Liabilities 80.04
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 131.16
Operating Income -212.27
Net Income -95.50

Cash Flow Statement (mra) ($M)
Cash From Operations -78.11
Cash from Investing -230.99
Cash from Financing 203.29

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Ra Capital Management, L.p. 5.70 -26.30
02-12 13G/A Fmr Llc 12.80 14.18
11-14 13G/A Atlas Venture Fund XI, L.P. 5.50 -19.48
08-05 13D/A AI Day1 LLC 13.15 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-06 10-Q f UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 214,902 1,185,774 18.12
2025-04-10 237,098 1,124,781 21.08
2025-04-09 834,452 1,998,336 41.76
2025-04-08 343,156 1,056,139 32.49
2025-04-07 310,323 1,209,052 25.67

(click for more detail)

Similar Companies
CRNX – Crinetics Pharmaceuticals, Inc. CTMX – CytomX Therapeutics, Inc.
CYTK – Cytokinetics, Incorporated DNLI – Denali Therapeutics Inc.
DSGN – Design Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io